Cargando…
Phenotypic heterogeneity in IGHV-mutated CLL patients has prognostic impact and identifies a subset with increased sensitivity to BTK and PI3Kδ inhibition
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4360209/ https://www.ncbi.nlm.nih.gov/pubmed/25349153 http://dx.doi.org/10.1038/leu.2014.308 |
| _version_ | 1782361514065264640 |
|---|---|
| author | Pepper, C Buggins, A G S Jones, C H Walsby, E J Forconi, F Pratt, G Devereux, S Stevenson, F K Fegan, C |
| author_facet | Pepper, C Buggins, A G S Jones, C H Walsby, E J Forconi, F Pratt, G Devereux, S Stevenson, F K Fegan, C |
| author_sort | Pepper, C |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4360209 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-43602092015-03-17 Phenotypic heterogeneity in IGHV-mutated CLL patients has prognostic impact and identifies a subset with increased sensitivity to BTK and PI3Kδ inhibition Pepper, C Buggins, A G S Jones, C H Walsby, E J Forconi, F Pratt, G Devereux, S Stevenson, F K Fegan, C Leukemia Letter to the Editor Nature Publishing Group 2015-03 2014-11-18 /pmc/articles/PMC4360209/ /pubmed/25349153 http://dx.doi.org/10.1038/leu.2014.308 Text en Copyright © 2015 Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
| spellingShingle | Letter to the Editor Pepper, C Buggins, A G S Jones, C H Walsby, E J Forconi, F Pratt, G Devereux, S Stevenson, F K Fegan, C Phenotypic heterogeneity in IGHV-mutated CLL patients has prognostic impact and identifies a subset with increased sensitivity to BTK and PI3Kδ inhibition |
| title | Phenotypic heterogeneity in IGHV-mutated CLL patients has prognostic impact and identifies a subset with increased sensitivity to BTK and PI3Kδ inhibition |
| title_full | Phenotypic heterogeneity in IGHV-mutated CLL patients has prognostic impact and identifies a subset with increased sensitivity to BTK and PI3Kδ inhibition |
| title_fullStr | Phenotypic heterogeneity in IGHV-mutated CLL patients has prognostic impact and identifies a subset with increased sensitivity to BTK and PI3Kδ inhibition |
| title_full_unstemmed | Phenotypic heterogeneity in IGHV-mutated CLL patients has prognostic impact and identifies a subset with increased sensitivity to BTK and PI3Kδ inhibition |
| title_short | Phenotypic heterogeneity in IGHV-mutated CLL patients has prognostic impact and identifies a subset with increased sensitivity to BTK and PI3Kδ inhibition |
| title_sort | phenotypic heterogeneity in ighv-mutated cll patients has prognostic impact and identifies a subset with increased sensitivity to btk and pi3kδ inhibition |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4360209/ https://www.ncbi.nlm.nih.gov/pubmed/25349153 http://dx.doi.org/10.1038/leu.2014.308 |
| work_keys_str_mv | AT pepperc phenotypicheterogeneityinighvmutatedcllpatientshasprognosticimpactandidentifiesasubsetwithincreasedsensitivitytobtkandpi3kdinhibition AT bugginsags phenotypicheterogeneityinighvmutatedcllpatientshasprognosticimpactandidentifiesasubsetwithincreasedsensitivitytobtkandpi3kdinhibition AT jonesch phenotypicheterogeneityinighvmutatedcllpatientshasprognosticimpactandidentifiesasubsetwithincreasedsensitivitytobtkandpi3kdinhibition AT walsbyej phenotypicheterogeneityinighvmutatedcllpatientshasprognosticimpactandidentifiesasubsetwithincreasedsensitivitytobtkandpi3kdinhibition AT forconif phenotypicheterogeneityinighvmutatedcllpatientshasprognosticimpactandidentifiesasubsetwithincreasedsensitivitytobtkandpi3kdinhibition AT prattg phenotypicheterogeneityinighvmutatedcllpatientshasprognosticimpactandidentifiesasubsetwithincreasedsensitivitytobtkandpi3kdinhibition AT devereuxs phenotypicheterogeneityinighvmutatedcllpatientshasprognosticimpactandidentifiesasubsetwithincreasedsensitivitytobtkandpi3kdinhibition AT stevensonfk phenotypicheterogeneityinighvmutatedcllpatientshasprognosticimpactandidentifiesasubsetwithincreasedsensitivitytobtkandpi3kdinhibition AT feganc phenotypicheterogeneityinighvmutatedcllpatientshasprognosticimpactandidentifiesasubsetwithincreasedsensitivitytobtkandpi3kdinhibition |